- Abstract:
-
BACKGROUND: Combretastatin A-4-phosphate (CA-4-P) is a microtubule depolymerising agent currently in clinical trial as a tumour vascular-targeting agent. In vivo, CA-4-P causes rapid shutdown of tumour blood flow (within minutes) and a significant neutrophil infiltration at later times. MATERIALS AND METHODS: Using an in vitro flow-cell assay, we investigated neutrophil-endothelial cell interactions and associated mechanisms, following endothelial cell exposure to CA-4-P. Cellular adhesion m...
Expand abstract - Publication status:
- Published
- Journal:
- Anticancer research
- Volume:
- 23
- Issue:
- 4
- Pages:
- 3199-3206
- Publication date:
- 2003
- EISSN:
-
1791-7530
- ISSN:
-
0250-7005
- URN:
-
uuid:f128434d-bd74-43d7-841c-21ea1f9dae4d
- Source identifiers:
-
130857
- Local pid:
- pubs:130857
- Copyright date:
- 2003
Journal article
The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record